Gastric acid reflux is actually associated with cervical cancer

Share This Post

People are familiar with the uncomfortable feeling of acid reflux. A recent US study found that gastroesophageal reflux disease (GORD) may increase the risk of laryngeal cancer , tonsil, and some sinus cancers in the elderly .

Experts say that this study does not prove causality, but the results of the study emphasize that if acid reflux becomes a long-term problem, you must seek medical treatment as soon as possible.

The main symptom of acid reflux is heartburn, which feels like the center of the chest is burning. You may also taste a strange sour taste in your mouth. This is because in people with GORD, stomach acid can seep into the esophagus, which is the food tube that leads to the throat.

The study involved 13,805 American men and women aged 66 and over who had cancers of the respiratory tract and neck. The researchers found that the most common cause of acid reflux is the throat, and the weakest is the sinuses.

Overall, older people with this disease are more than twice as likely to be diagnosed with certain neck cancers as without GORD. This study has certain limitations, especially the additional risks posed by drinking and smoking are not taken into account. However, it is necessary to identify people at risk, improve monitoring, and find early diagnosis and treatment.

This study did find a link, but did not take into account the risk factors of these cancer types, such as smoking and drinking, and if so, what is the role of acid reflux.

The British National Health Insurance system recommends that if you have stomach upsets, you should try:

Ø Eat less and eat more meals;

Ø Raise the head of the bed by 10-20cm, or put something on it to ensure that stomach acid will not flow back to the throat;

Ø If it is important to lose weight;

Ø Relax yourself.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy